Shares of Health Care sector company Abcam moved 0.3% today, and are now trading at a price of $22.51. The mid-cap stock's daily volume was 1,247,930 compared to its average volume of 1,815,825. The S&P 500 index returned a -1.0% performance.
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. The company is based in Cambridge and has 1,760 full time employees. Its market capitalization is $5,171,064,832.
5 analysts are following Abcam and have set target prices ranging from $17.05 to $40.12 per share. On average, they have given the company a rating of buy. At today's prices, ABCM is trading -16.26% away from its average analyst target price of $26.88 per share.
|Date Reported||Cash Flow from Operations ($ k)||Capital expenditures ($ k)||Free Cashflow ($ k)||YoY Growth (%)|